Analysis of information sources in references of the Wikipedia article "TLX" in English language version.
Last modified:
While TLX/NR2E1 has been a promising therapeutic target given its critical role in neural stem cell biology (Benod et al., 2014), its classification as an orphan nuclear receptor (with no known endogenous ligand) has hampered its utilization. However, Kandel and collaborators recently identified this long-sought endogenous ligand to be the mono-unsaturated fatty acid cis18:1ω9, oleic acid, thereby de-orphanizing this important receptor (Kandel et al., 2022). The discovery of the endogenous ligand made the TLX/NR2E1 (i.e. oleic acid receptor) a druggable target that could at the same time increase neurogenesis and alleviate neuroinflammation, both affected by radiation. However, while it would be the easiest to stimulate TLX/NR2E1 by its ligand, oleic acid, this is not possible as this fatty acid does not easily penetrate blood-brain-barrier.
While TLX/NR2E1 has been a promising therapeutic target given its critical role in neural stem cell biology (Benod et al., 2014), its classification as an orphan nuclear receptor (with no known endogenous ligand) has hampered its utilization. However, Kandel and collaborators recently identified this long-sought endogenous ligand to be the mono-unsaturated fatty acid cis18:1ω9, oleic acid, thereby de-orphanizing this important receptor (Kandel et al., 2022). The discovery of the endogenous ligand made the TLX/NR2E1 (i.e. oleic acid receptor) a druggable target that could at the same time increase neurogenesis and alleviate neuroinflammation, both affected by radiation. However, while it would be the easiest to stimulate TLX/NR2E1 by its ligand, oleic acid, this is not possible as this fatty acid does not easily penetrate blood-brain-barrier.
While TLX/NR2E1 has been a promising therapeutic target given its critical role in neural stem cell biology (Benod et al., 2014), its classification as an orphan nuclear receptor (with no known endogenous ligand) has hampered its utilization. However, Kandel and collaborators recently identified this long-sought endogenous ligand to be the mono-unsaturated fatty acid cis18:1ω9, oleic acid, thereby de-orphanizing this important receptor (Kandel et al., 2022). The discovery of the endogenous ligand made the TLX/NR2E1 (i.e. oleic acid receptor) a druggable target that could at the same time increase neurogenesis and alleviate neuroinflammation, both affected by radiation. However, while it would be the easiest to stimulate TLX/NR2E1 by its ligand, oleic acid, this is not possible as this fatty acid does not easily penetrate blood-brain-barrier.